SRRK
Scholar Rock Holding Corp
Halal Rating :
Last Price
$43.17
Last updated:
Market Cap
-
7D Change
1.34%
1 Year Change
180.51%
Company Overview
Industries
Exchange
Next Earnings Date
Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company's lead product candidate is apitegromab, which is in Phase 3 clinical development for the treatment of spinal muscular atrophy (SMA).
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Scholar Rock Holding Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.